Myeongjin Jeon

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Design of a heteroleptic green Ir(iii) complex for eco-friendly solution-processed phosphorescent organic light-emitting diodes with external quantum efficiency exceeding 22.

Design of a heteroleptic green Ir(iii) complex for eco-friendly solution-processed phosphorescent organic light-emitting diodes with external quantum efficiency exceeding 22.

Journal: RSC advances

Published: December 06, 2024

Targeting FAK/PYK2 with SJP1602 for Anti-Tumor Activity in Triple-Negative Breast Cancer.

Targeting FAK/PYK2 with SJP1602 for Anti-Tumor Activity in Triple-Negative Breast Cancer.

Journal: Current issues in molecular biology

Published: August 01, 2023

Targeting RAF Isoforms and Tumor Microenvironments in RAS or BRAF Mutant Colorectal Cancers with SJ-C1044 for Anti-Tumor Activity.

Targeting RAF Isoforms and Tumor Microenvironments in RAS or BRAF Mutant Colorectal Cancers with SJ-C1044 for Anti-Tumor Activity.

Journal: Current issues in molecular biology

Published: June 04, 2023

Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells.

Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: June 26, 2017

Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction.

Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction.

Journal: Oncotarget

Published: April 14, 2016

Elevated IL-1β expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone.

Elevated IL-1β expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone.

Journal: Chemico-biological interactions

Published: March 02, 2016

STC-1 expression is upregulated through an Akt/NF-κB-dependent pathway in triple-negative breast cancer cells.

STC-1 expression is upregulated through an Akt/NF-κB-dependent pathway in triple-negative breast cancer cells.

Journal: Oncology reports

Published: March 02, 2016

Elevated STC‑1 augments the invasiveness of triple‑negative breast cancer cells through activation of the JNK/c‑Jun signaling pathway.

Elevated STC‑1 augments the invasiveness of triple‑negative breast cancer cells through activation of the JNK/c‑Jun signaling pathway.

Journal: Oncology reports

Published: January 05, 2016

Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression.

Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: November 01, 2015

MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells.

MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells.

Journal: Oncology reports

Published: October 21, 2015

MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells.

MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: September 06, 2015

Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.

Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.

Journal: Oncotarget

Published: June 30, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026